New Possibilities for the Treatment of Poor Prognosis Breast Cancer
A recent study declared that the TLR9 protein expressed by cancer cells has an effect on the prognosis of triple-negative breast cancer. The new discovery creates possibilities for the development of much needed cancer therapy and medication. In the future, it may benefit hundreds of Finnish women.
Researcher Johanna Tuominen works with cell and molecular biology.